Janssen Receives Positive CHMP Opinion Recommending EDURANT®▼ (rilpivirine) for the Treatment of Adolescents Aged 12 to <18 Years with HIV-1 infection
- EMEA Innovative Medicine
- Janssen Receives Positive CHMP Opinion Recommending EDURANT®▼ (rilpivirine) for the Treatment of Adolescents Aged 12 to <18 Years with HIV-1 infection
Janssen Receives Positive CHMP Opinion Recommending EDURANT®▼ (rilpivirine) for the Treatment of Adolescents Aged 12 to <18 Years with HIV-1 infection
- X (Twitter)
Copy link